FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Fortrea Holdings Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$22.42−0.07 (-0.31%)
Close on Oct 19, 2026
- Market cap
- $2.13B
- P/E (TTM)
- –
- Dividend yield
- –
Fortrea Holdings Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Services Segment | $2.68B | $2.71B | $2.72B | $2.76B | $2.73B | $2.69B | $2.70B | $2.71B | $2.75B | $2.81B | $2.84B | – | 100.0% | -2.1% |
| Enabling Services | – | – | – | – | – | – | – | – | – | – | $269.50M | – | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Services Segment | -$10.80M | -$355.90M | -$872.60M | -$914.60M | -$924.00M | -$644.60M | -$161.90M | -$266.70M | -$188.80M | -$63.80M | $32.00M | – | -98.8% |
| Enabling Services | – | – | – | – | – | – | – | – | – | – | $11.40M | – | – |
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | $1.25B | $1.28B | $1.29B | $1.31B | $1.30B | $1.27B | $1.27B | $1.27B | $1.30B | $1.35B | $1.40B | $1.24B | 46.8% | -3.6% |
| Europe | $866.30M | $865.30M | $851.70M | $837.10M | $815.70M | $792.90M | $800.00M | $822.80M | $835.30M | $839.80M | $827.50M | $800.00M | 32.4% | +6.2% |
| Other | $557.90M | $566.40M | $582.10M | $611.20M | $619.20M | $620.50M | $626.90M | $618.00M | $614.60M | $620.40M | $616.60M | $598.60M | 20.8% | -9.9% |
From the segment and revenue-disaggregation notes of Fortrea's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.